Moderna COVID-19 vaccine shows 94.1% efficacy in trial: Study
The study enrolled 30,420 adult participants at 99 sites in the U.S., including over 600 participants enrolled at the Brigham.
Full Article
Moderna COVID-19 vaccine shows 94.1% efficacy in trial: Study
Hindu
0 shares
1 views
You might like
Related news coverage
Moderna COVID-19 Vaccine Trial Shows 94.1 Percent Efficacy
Eurasia Review
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which..
Advertisement
More coverage
Chinese Sinovac covid vaccine more than 50% effective, but data withheld
WorldNews
A Covid-19 vaccine developed by Chinese pharmaceutical firm Sinovac Biotech Ltd. was found to be more than 50% effective in a..
-
AstraZeneca: ‘Winning’ vaccine formula is 100% effective against severe COVID-19
Upworthy
-
NA Proactive news snapshot: Mirasol Resources, BetterLife Pharma, Victory Resources, Todos Medical ...
Proactive Investors
-
BioNTech, Moderna say approved COVID-19 vaccines should protect against new strain
Proactive Investors
-
COVAXIN crosses half-way mark in phase 3 clinical trials with 13,000 volunteers
Zee News